Back

Tobacco industry interference and WHO FCTC Article 5.3 implementation in Aotearoa New Zealand: A qualitative analysis

Gregan, M.-J.; Wiles, J.; Nosa, V.; Wikaire, E.; Adams, P. A.

2026-02-26 public and global health
10.64898/2026.02.24.26346935 medRxiv
Show abstract

BackgroundArticle 5.3 of the WHO Framework Convention on Tobacco Control requires Parties to protect policies from tobacco industry interference, yet implementation remains weak internationally. Aotearoa New Zealands (Aotearoa NZ) is seen as a leader in tobacco control, yet little is known about its implementation of Article 5.3 protections. This study examines these protections as well as existing transparency measures in light of the 2024 repeal of world-leading tobacco control policies. MethodsInterviews with current and former: public health experts, politicians, officials and political journalists, and analysis of key texts. ResultsAotearoa NZs Article 5.3 implementation and scope is constrained, leaving invisible and exploitable paths of influence. Public health experts argued protections have been neglected from the start. Politicians were unaware of Article 5.3 obligations, and reported limited guidance on industry interactions. These gaps are compounded by non-existent lobbying laws and ill-equipped transparency measures. ConclusionDespite the countrys reputation for strong tobacco controls, structural policy and implementation failures leave Aotearoa NZs health policies vulnerable to industry interference. Aotearoa NZ and other Parties should consider institutionally embedding comprehensive Article 5.3 protections to safeguard policy decisions from tobacco industry influence. WHAT THIS PAPER ADDSO_ST_ABSWhat is already known on this topicC_ST_ABSTobacco industry interference remains the biggest barrier to tobacco control policies, with evidence consistently identifying gaps in Parties implementation of Framework Convention on Tobacco Control Article 5.3 protections. Parties often rely on pre-existing measures such as lobbying laws. What this study addsThis is the first study examing Aotearoa NZs implementation of Article 5.3. It shows that despite its reputation as a tobacco control leader, implementation is severely limited and pre-existing measures are inadequate, enabling a system in which industry interference can go on unseen. How this study might affect research, practice or policyBy identifying how structural policy gaps enable industry interference, this study highlights the need for comprehensive institutional embedding of Article 5.3 protections across government, and consideration of its codification into law.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 9%
18.6%
2
BMC Public Health
147 papers in training set
Top 0.1%
14.3%
3
PLOS Global Public Health
293 papers in training set
Top 0.8%
10.4%
4
BMJ Open
554 papers in training set
Top 3%
6.8%
50% of probability mass above
5
International Journal of Environmental Research and Public Health
124 papers in training set
Top 1%
4.8%
6
BMJ Global Health
98 papers in training set
Top 0.8%
4.0%
7
Frontiers in Public Health
140 papers in training set
Top 2%
3.6%
8
BMC Health Services Research
42 papers in training set
Top 0.8%
2.7%
9
Cureus
67 papers in training set
Top 2%
1.9%
10
International Journal of Drug Policy
11 papers in training set
Top 0.2%
1.7%
11
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
1.7%
12
Journal of Public Health
23 papers in training set
Top 0.5%
1.5%
13
Public Health in Practice
11 papers in training set
Top 0.1%
1.3%
14
JMIR Public Health and Surveillance
45 papers in training set
Top 2%
1.3%
15
Nicotine & Tobacco Research
11 papers in training set
Top 0.1%
1.3%
16
Disaster Medicine and Public Health Preparedness
16 papers in training set
Top 1%
0.9%
17
Thorax
32 papers in training set
Top 0.7%
0.9%
18
Public Health
34 papers in training set
Top 2%
0.7%
19
Preventive Medicine Reports
14 papers in training set
Top 0.5%
0.7%
20
F1000Research
79 papers in training set
Top 6%
0.6%
21
Preventive Medicine
11 papers in training set
Top 0.5%
0.6%